Ncri Petrea Trial: A Phase 3 Evaluation of Pet-Guided, Response-Adapted Therapy in Patients With Previously Untreated, Advanced-Stage, High-Tumour-Burden Follicular Lymphoma
Hematological Oncology - United Kingdom
doi 10.1002/hon.35_2629
Full Text
Open PDFAbstract
Available in full text
Date
June 1, 2019
Authors
Publisher
Wiley